Quanta Dialysis Technologies Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
205
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$60.3M
- Investors
-
28
Quanta Dialysis Technologies General Information
Description
Manufacturer of a medical device intended to improve dialysis experiences and kidney care. The company's dialysis machine is high-performing, small and simple, supports high dialysate flow rates, and provides real-time feedback, enabling healthcare providers to treat more patients efficiently and to take control of their lives with self-care and home dialysis.
Contact Information
Website
www.quantadt.comCorporate Office
- The Woods, Haywood Road
- Warwick CV34 5AH
- England, United Kingdom
Corporate Office
- The Woods, Haywood Road
- Warwick CV34 5AH
- England, United Kingdom
Quanta Dialysis Technologies Timeline
Quanta Dialysis Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series E) | 18-Nov-2024 | $60.3M | Completed | Generating Revenue | ||
| 10. Later Stage VC | 18-Jun-2023 | Completed | Generating Revenue | |||
| 9. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 8. Later Stage VC (Series D) | 23-Jun-2021 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 29-Jul-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 21-Jul-2018 | Completed | Generating Revenue | |||
| 5. Debt - General | 31-Mar-2016 | Completed | Generating Revenue | |||
| 4. Grant | 18-Aug-2015 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 01-Dec-2014 | $42.1M | $56.8M | Completed | Startup | |
| 2. Grant | 29-Sep-2012 | $14.7M | Completed | Startup |
Quanta Dialysis Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| E1 Preferred | ||||||||
| Ordinary | ||||||||
| Series D2 | ||||||||
| Series D1 | ||||||||
| C Preferred | ||||||||
| B Preferred | ||||||||
| B Preferred | ||||||||
| A Preferred | ||||||||
| A Preferred | 3,516,400 | $0.012896 | $1.16 | $1.16 | 1x | $1.16 | 0.07% | |
| A Preferred | 3,214,300 | $0.012896 | $0.9 | $0.9 | 1x | $0.9 | 0.07% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Quanta Dialysis Technologies Comparisons
Industry
Financing
Details
Quanta Dialysis Technologies Competitors (13)
One of Quanta Dialysis Technologies’s 13 competitors is Peripal, a Formerly VC-backed company based in Zurich, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Peripal | Formerly VC-backed | Zurich, Switzerland | ||||
| Terumo | Corporation | Tokyo, Japan | ||||
| BPL Medical Technologies | Private Equity-Backed | Arakere, India | ||||
| B. Braun | Corporation | Melsungen, Germany | ||||
| AccuVein | Venture Capital-Backed | Medford, NY |
Quanta Dialysis Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Quanta Dialysis Technologies Patents
Quanta Dialysis Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202400291-D0 | Dialysis fluid cartridge | Pending | 09-Jan-2024 | ||
| GB-202209928-D0 | Operation of a dialysis system | Pending | 06-Jul-2022 | ||
| GB-2620408-A | Operation of a dialysis system | Pending | 06-Jul-2022 | ||
| GB-202116872-D0 | Infusate bag spike | Pending | 23-Nov-2021 | ||
| GB-2613150-A | Infusate bag spike | Pending | 23-Nov-2021 | A61M5/162 |
Quanta Dialysis Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Quanta Dialysis Technologies Investors (28)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ancora ( Business/Productivity Software) | Corporation | Minority | ||
| BlackRock | Asset Manager | Minority | ||
| Eldridge Industries | Holding Company | Minority | ||
| Glenview Capital Management | Hedge Fund | Minority | ||
| Millennium Management | Hedge Fund | Minority |
Quanta Dialysis Technologies FAQs
-
When was Quanta Dialysis Technologies founded?
Quanta Dialysis Technologies was founded in 2008.
-
Where is Quanta Dialysis Technologies headquartered?
Quanta Dialysis Technologies is headquartered in Warwick, United Kingdom.
-
What is the size of Quanta Dialysis Technologies?
Quanta Dialysis Technologies has 205 total employees.
-
What industry is Quanta Dialysis Technologies in?
Quanta Dialysis Technologies’s primary industry is Other Devices and Supplies.
-
Is Quanta Dialysis Technologies a private or public company?
Quanta Dialysis Technologies is a Private company.
-
What is the current valuation of Quanta Dialysis Technologies?
The current valuation of Quanta Dialysis Technologies is .
-
What is Quanta Dialysis Technologies’s current revenue?
The current revenue for Quanta Dialysis Technologies is .
-
How much funding has Quanta Dialysis Technologies raised over time?
Quanta Dialysis Technologies has raised $425M.
-
Who are Quanta Dialysis Technologies’s investors?
Ancora ( Business/Productivity Software), BlackRock, Eldridge Industries, Glenview Capital Management, and Millennium Management are 5 of 28 investors who have invested in Quanta Dialysis Technologies.
-
Who are Quanta Dialysis Technologies’s competitors?
Peripal, Terumo, BPL Medical Technologies, B. Braun, and AccuVein are some of the 13 competitors of Quanta Dialysis Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
